Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 2/20 | 0.73 |
| ▸ | TSHR | P16473 | 1/20 | 0.56 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.45 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.45 |
| ▸ | LPAR2 | Q9HBW0 | 2/20 | 0.45 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4380228 | 0.95 | CYP3A4 (0.73) | CYP3A4TSHRLPAR3LPAR1LPAR2 | |
| SCHEMBL178107 | 0.93 | CYP3A4 (0.62) | CYP3A4TSHRLPAR3LPAR1LPAR2 | |
| SCHEMBL1261050 | 0.91 | CYP3A4 (0.60) | CYP3A4TSHRLPAR3LPAR1LPAR2 | |
| SCHEMBL11350922 | 0.91 | CYP3A4 (0.60) | CYP3A4TSHRLPAR3LPAR1LPAR2 | |
| SCHEMBL5850379 | 0.91 | CYP3A4 (0.60) | CYP3A4TSHRLPAR3LPAR1LPAR2 | |
| SCHEMBL28608720 | 0.91 | CYP3A4 (0.60) | CYP3A4TSHRLPAR3LPAR1LPAR2 | |
| SCHEMBL7780302 | 0.91 | CYP3A4 (0.60) | CYP3A4TSHRLPAR3LPAR1LPAR2 | |
| SCHEMBL177766 | 0.91 | CYP3A4 (0.60) | CYP3A4TSHRLPAR3LPAR1LPAR2 | |
| SCHEMBL177972 | 0.91 | CYP3A4 (0.60) | CYP3A4TSHRLPAR3LPAR1LPAR2 | |
| SCHEMBL251881 | 0.88 | CYP3A4 (0.62) | CYP3A4TSHRLPAR3LPAR1LPAR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 86 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119350511-A | Uranium thorium specific capture agent in complex solution system, synthesis method and application thereof | 浙江创欣新材料有限公司 | 2025-01-24 | — | — | CN | claimed |
| CN-119143832-A | Abiraterone acetate and preparation method thereof | 黄冈人福药业有限责任公司 | 2024-12-17 | — | — | CN | claimed |
| CN-112409599-B | Hyperbranched silicon-based resin flame retardant containing phosphorus-oxygen functionalized and preparation method thereof | 山东天一化学股份有限公司 | 2023-01-24 | — | — | CN | claimed |
| CN-114773417-A | Cordycepin phosphate and preparation method and application thereof | 郑州大学 | 2022-07-22 | — | — | CN | claimed |
| CN-112480412-A | Acetoacetyl functionalized phosphorus-containing resin flame retardant and preparation method thereof | 山东天一化学股份有限公司 | 2021-03-12 | — | — | CN | claimed |
| CN-112409599-A | Hyperbranched silicon-based resin flame retardant containing phosphorus-oxygen functionalized and preparation method thereof | 山东天一化学股份有限公司 | 2021-02-26 | — | — | CN | claimed |
| US-5734064-A | Process for the preparation of carboxylic acid succinimidyl esters | DSM CHEMIE LINZ GMBH (AT) | 1998-03-31 | — | — | US | claimed |
| JP-10036345-A | — | — | None | — | — | JP | disclosed |
| EP-3801553-B1 | PRODRUGS OF FULVESTRANT | KASHIV BIOSCIENCES LLC (US) | 2026-03-25 | — | — | EP | disclosed |
| US-20260015372-A1 | Organophosphorous Compounds and Uses Thereof | JAL THERAPEUTICS LLC (US) | 2026-01-15 | — | — | US | disclosed |
| CN-119350511-A | Uranium thorium specific capture agent in complex solution system, synthesis method and application thereof | 浙江创欣新材料有限公司 | 2025-01-24 | — | — | CN | disclosed |
| US-12191448-B2 | Nonaqueous electrolyte solution for secondary battery, and secondary battery provided with said solution | STELLA CHEMIFA CORPORATION (JP) | 2025-01-07 | — | — | US | disclosed |
| CN-119143832-A | Abiraterone acetate and preparation method thereof | 黄冈人福药业有限责任公司 | 2024-12-17 | — | — | CN | disclosed |
| US-3983065-A | Solid, rapid-setting, rigid polyurethanes | THE DOW CHEMICAL COMPANY (US) | 1976-09-28 | — | — | US | disclosed |
| US-3983064-A | Solid, rapid-setting, rigid polyurethanes | THE DOW CHEMICAL COMPANY (US) | 1976-09-28 | — | — | US | disclosed |
| US-3983066-A | Solid, rapid setting, rigid polyurethanes | THE DOW CHEMICAL COMPANY (US) | 1976-09-28 | — | — | US | disclosed |
| US-3966662-A | Solid, rapid-setting, rigid polyurethanes | THE DOW CHEMICAL COMPANY (US) | 1976-06-29 | — | — | US | disclosed |
| US-3966664-A | Solid, rapid-setting, rigid polyurethanes | THE DOW CHEMICAL COMPANY (US) | 1976-06-29 | — | — | US | disclosed |
| US-3965073-A | Preparation of rapid setting non-elastomeric polyurethane compositions in the presence of ester-modified polyoxyalkylene compounds | THE DOW CHEMICAL COMPANY (US) | 1976-06-22 | — | — | US | disclosed |
| US-3956221-A | Rapid setting non-elastomeric polyurethane compositions containing a non-hydroxyl containing ester-modified polyoxylkylene compound | THE DOW CHEMICAL COMPANY (US) | 1976-05-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260015372-A1 | Organophosphorous Compounds and Uses Thereof | ACHE, BCHE, MUSK | CYP3A4 1005/4885TSHR 708/4885LPAR3 1951/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.